Psoriasis

Guidelines (7)

Ixekizumab for Treating Moderate to Severe Plaque Psoriasis (TA442)

26 April 2017

Apremilast for Treating Moderate to Severe Plaque Psoriasis (TA419)

23 November 2016

Secukinumab for Treating Moderate to Severe Plaque Psoriasis (TA350)

22 July 2015

Ustekinumab for the Treatment of Adults with Moderate to Severe Psoriasis (TA180)

25 September 2009

Psoriasis, Treatment of Adults: Adalimumab (NICE)

23 June 2008

Psoriasis in Adults: Infliximab (NICE)

23 January 2008

Psoriasis in Adults: Etanercept and Efalizumab (NICE)

14 September 2006

Drug Sections (1)

Psoriasis in the News

NICE approves guselkumab for plaque psoriasis

NICE approves guselkumab for plaque psoriasis

By Sandhiya Sodha, 14 June 2018

Guselkumab (Tremfya) is now an option for routine NHS...

Psoriasis biologic approved for NHS prescribing

Psoriasis biologic approved for NHS prescribing

By Sandhiya Sodha, 23 March 2018

Brodalumab (Kyntheum) can now be prescribed routinely...

Guselkumab further extends choice in psoriasis prescribing

Guselkumab further extends choice in psoriasis prescribing

By Lisa Lytle, 28 November 2017

Tremfya (guselkumab) is licensed for the treatment...

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Twitter